Remote check for nerve damage in cancer survivors shows promise

NCT ID NCT06747910

Recruiting now Diagnosis Sponsor: St. Jude Children's Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study looks at whether a wearable heart monitor and a symptom questionnaire can accurately detect autonomic dysfunction—a condition affecting heart rate and blood pressure control—in survivors of childhood leukemia and lymphoma. Researchers will compare these remote methods to standard in-person tests in 188 adult survivors. If the remote tools work well, they could make diagnosis faster and easier, potentially reducing health risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: biosensor heart monitor and questionnaire
What this could lead to: If successful, this could allow doctors to diagnose autonomic dysfunction in cancer survivors remotely, without needing an in-person visit.
What could go wrong: This is an early diagnostic study, not a treatment trial. The remote methods may not be as accurate as in-person testing, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lymphoblastic leukemia childhood malignant neoplasm Hodgkins lymphoma neoplasm non-Hodgkin lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDHOOD CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

St. Jude Children's Research Hospital
RECRUITING

Memphis, Tennessee, 38105, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.